GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹542 Cr | ₹419 Cr | ₹1,066 Cr | ₹921 Cr | ₹1,218 Cr |
What is the latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹542 Cr |
| Mar2024 | ₹419 Cr |
| Mar2023 | ₹1,066 Cr |
| Mar2022 | ₹921 Cr |
| Mar2021 | ₹1,218 Cr |
How is Capital Work in Progress of GLENMARK PHARMACEUTICALS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹542 Cr | 29.25 | |
| Mar2024 | ₹419 Cr | -60.66 | |
| Mar2023 | ₹1,066 Cr | 15.71 | |
| Mar2022 | ₹921 Cr | -24.36 | |
| Mar2021 | ₹1,218 Cr | - | |
Compare Capital Work in Progress of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹63,097.1 Cr | -2.9% | 4.7% | 20.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -2.9% |
4.7% |
20.1% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses